Beranda › Mielofibrosis › New York › New York City
Uji klinis Mielofibrosis di New York City, NY
18 studi untuk Mielofibrosis mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Menerima pesertaFase 1/2
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical Center, New York
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Menerima pesertaFase 3
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Menerima pesertaFase 2
- NYP/Weill Cornell Medical Center, New York
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore, New York
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Menerima pesertaFase 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Menerima pesertaFase 1
- Icahn School of Medicine At Mount Sinai, New York
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Menerima pesertaFase 1
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai School of Medicine, New York
- Weill Cornell Medicine, New York
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Menerima pesertaFase 2
- Ruttenberg Treatment Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NewYork-Presbyterian/Weill Cornell Medical Center, New York
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
Menerima pesertaFase 2
- GSK Investigational Site, New York
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Menerima pesertaFase 1
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Menerima pesertaFase 2
- Memorial Sloan Kettering, New York
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Menerima pesertaFase 2
- Weill Cornell Medicine NewYork-Presbyterian, New York
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
Menerima pesertaStudi observasional
- Memorial Sloan Kettering Cancer Center, New York
MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
Menerima pesertaFase 2
- Ruttenberg Treatment Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, New York
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Menerima pesertaFase 3
- ICAHN School of Medicine at Mount Sinai, New York
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Menerima pesertaFase 1
- Columbia University, New York
Uji klinis Mielofibrosis di kota lain
- Houston, TX19 studi
- Boston, MA12 studi
- Durham, NC12 studi
- Columbus, OH11 studi
- Seattle, WA11 studi
- Salt Lake City, UT10 studi
- Miami, FL10 studi
- Nashville, TN9 studi
- Baldwin Park, CA9 studi
- Atlanta, GA9 studi
- Tampa, FL9 studi
- Cleveland, OH9 studi
Studi lain di New York City
- Kanker Payudara136 studi
- Kanker Paru Non-Sel Kecil121 studi
- Kanker (semua jenis)109 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal78 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Mieloma Multipel60 studi
- Kanker Pankreas60 studi
- Kanker Endometrium52 studi
- Leukemia Mieloid Akut51 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.